EyePoint Pharmaceuticals Inc. sell StockNews.com
Start price
04.03.23
/
50%
€3.04
Target price
04.03.24
-
Performance (%)
669.74%
End price
05.03.24
€23.40
Summary
This prediction ended on 05.03.24 with a price of €23.40. The SELL prediction by StockNews_com for EyePoint Pharmaceuticals Inc. was trending in the completely wrong direction and closed with a performance of 669.74%. StockNews_com has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -11.223% | -11.223% | -3.813% |
| iShares Core DAX® | 3.523% | 3.763% | 26.705% |
| iShares Nasdaq 100 | 1.026% | 2.380% | 29.587% |
| iShares Nikkei 225® | -0.063% | 0.000% | 15.214% |
| iShares S&P 500 | 0.557% | 2.222% | 27.662% |
Comments by StockNews_com for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.17
21.09.24
21.09.24
-
21.09.25
21.09.25
-8.62%
27.09.24
27.09.24
